VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/32387333/

⇱ Could nasal nitric oxide help to mitigate the severity of COVID-19? - PubMed


Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
👁 Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

👁 Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

The nasal cavity and turbinates play important physiological functions by filtering, warming and humidifying inhaled air. Paranasal sinuses continually produce nitric oxide (NO), a reactive oxygen species that diffuses to the bronchi and lungs to produce bronchodilatory and vasodilatory effects. Studies indicate that NO may also help to reduce respiratory tract infection by inactivating viruses and inhibiting their replication in epithelial cells. In view of the pandemic caused by the novel coronavirus (SARS-CoV-2), clinical trials have been designed to examine the effects of inhaled nitric oxide in COVID-19 subjects. We discuss here additional lifestyle factors such as mouth breathing which may affect the antiviral response against SARS-CoV-2 by bypassing the filtering effect of the nose and by decreasing NO levels in the airways. Simple devices that promote nasal breathing during sleep may help prevent the common cold, suggesting potential benefits against coronavirus infection. In the absence of effective treatments against COVID-19, the alternative strategies proposed here should be considered and studied in more detail.

Keywords: Breathing; COVID-19; Coronavirus; Innate immunity; Nitric oxide.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Y.-F.K. is President of Chang Gung Biotechnology Corporation. J.D.Y. is Chairman of the Board of Chang Gung Biotechnology Corporation. D.M.O. is an editor with Microbes and Infection. The other author (J.M.) declares that no competing interests.

Figures

👁 Fig. 1
Fig. 1
Potential effects of nasal breathing and nitric oxide on SARS-CoV-2 viral load and oxygenation. Nasal breathing may reduce viral load and improve oxygenation in COVID-19 subjects by filtering the air and by increasing NO levels in the airways. Several factors may reduce or increase the levels of nitric oxide as shown in the pink and green rectangles, respectively.

Comment in

References

    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. - PMC - PubMed
    1. Pan X., Ojcius D.M., Gao T., Li Z., Pan C. Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases. Microb Infect. 2020;22:86–91. - PMC - PubMed
    1. Teman N.R., Thomas J., Bryner B.S., Haas C.F., Haft J.W., Park P.K. Inhaled nitric oxide to improve oxygenation for safe critical care transport of adults with severe hypoxemia. Am J Crit Care. 2015;24:110–117. - PubMed
    1. Chen L., Liu P., Gao H., Sun B., Chao D., Wang F. Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing. Clin Infect Dis. 2004;39:1531–1535. - PMC - PubMed
Cite

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.